SCHEMBL8895041

SCHEMBL8895041

O=C1C(=O)c2cc3cc4ccccc4cc3cc2C=C1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.40
PTPRC P08575 5/20 0.39
S100A4 P26447 4/20 0.39
CES1 P23141 3/20 0.39
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
ALDH1A1 P00352 4/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
STAT6 P42226 1/20 0.37
HIF1A Q16665 1/20 0.37
PHLPP2 Q6ZVD8 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PTPN1 P18031 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4910366 0.97 PTPRC (0.41) CYP3A4PTPRCS100A4CES1BCHE
SCHEMBL8895903 0.79 PTPRC (0.33) CYP3A4PTPRCS100A4CES1BCHE
SCHEMBL6412225 0.78 CDC25B (0.46) CYP3A4PTPRCS100A4CES1BCHE
SCHEMBL7898478 0.75 ALDH1A1 (0.39) CYP3A4PTPRCS100A4CES1BCHE
SCHEMBL9405259 0.75 CES1 (0.47) CYP3A4PTPRCS100A4CES1BCHE
SCHEMBL10942136 0.75 ALDH1A1 (0.36) CYP3A4PTPRCS100A4CES1BCHE
SCHEMBL7945702 0.75 ALDH1A1 (0.39) CYP3A4PTPRCS100A4CES1BCHE
SCHEMBL4190455 0.72 S100A4 (0.49) PTPRCS100A4CES1BCHEACHE
SCHEMBL11424815 0.71 MAOB (0.38) PTPRCCES1ALDH1A1CYP1A2CYP2D6
SCHEMBL2059539 0.70 ALDH1A1 (0.38) CYP3A4PTPRCS100A4CES1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5594158-A Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1997-01-14 US claimed
EP-0523289-A1 Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin Board of Regents of the University of Nebraska (US) 1993-01-20 EP claimed